Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2

Veterinary Microbiology

Volumn 84, Issue 1-2, 2002, Pages 155-168

  Wisselink, Henk J ^a   Stockhofe Zurwieden, Norbert ^a   Hilgers, Luuk A T ^b   Smith, Hilde E ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b CoVaccine ^*  (Netherlands)

Author keywords

Capsular polysaccharides; Pig Bacteria; Protection; Streptococcus suis; Vaccines

Indexed keywords

ANTIBODY; BACTERIAL POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE; INACTIVATED VACCINE; LIVE VACCINE; MURAMIDASE RELEASED PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; AUTOPSY; BACTERIAL MEMBRANE; BACTERIUM MUTANT; CLINICAL EXAMINATION; CLINICAL FEATURE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; NONHUMAN; PROTECTION; SEROLOGY; STREPTOCOCCUS SUIS; SWINE;

ANIMALS; ANTIBODIES, BACTERIAL; COLONY COUNT, MICROBIAL; INJECTIONS, INTRAMUSCULAR; MUTATION; SPECIFIC PATHOGEN-FREE ORGANISMS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS SUIS; SWINE; SWINE DISEASES; TREATMENT OUTCOME; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS SUIS; SUS SCROFA;

EID: 0037011827     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(01)00452-7     Document Type: Article

References (26)

1. A selected water-in-oil emulsion: Composition and usefulness as an immunological adjuvant
2. Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain
3. Streptococcus suis serotype 2 mutants deficient in capsular expression
4. Detection of antibodies against Streptococcus suis capsular type 2 using a purified capsular polysaccharide antigen-based indirect ELISA
5. Antibody responses to pneumococcal vaccination in children younger than five years of age
6. Streptococcal infection in young pigs. V. An immonogenic polysaccharide from Streptococcus suis type 2 with particular reference to vaccination against the streptococcal meningitis in pigs
7. Isolation, characterization and protection studies in mice of a streptomycin-dependent mutant of Streptococcus suis type 1/2
8. Human immunity to the meningococcus. III. Preparation and immunochemical properties of the group A, group B and group C meningococcal polysaccharides
9. Description of 14 new capsular types Streptococcus suis
10. Characterization of six new capsular types (23 through 28) of Streptococcus suis
11. Description of six new capsular types (28 through 34) of Streptococcus suis
12. Immunisation of pigs with live cultures of Streptococcus suis type 2
13. Immunisation of pigs with killed cultures of Streptococcus suis type 2
14. Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis
15. Assessment of the pneumococcal polysaccharide vaccine
16. Isolation and characterization of temperature-sensitive mutants of Streptococcus suis: Efficacy trial of the mutant vaccine in mice
17. Serology of capsulated streptococci pathogenic for pigs: Six new serotypes of Streptococcus suis
18. Streptococcus suis infection in swine: A retrospective study of 256 cases. Part II. Clinical signs, gross and microscopic lesions, and coexisting microorganisms
19. Use of multiscreen plates for the preparation of bacterial DNA suitable for PCR
20. Identification and characterization of the cps locus of Streptococcus suis serotype 2: The capsule protects against phagocytosis and is an important virulence factor
21. Comparative studies on the pathogenicity of different Streptococcus suis serotype 1 strains
22. Streptococcus suis infections in pigs in the Netherlands (Part I)
23. Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype
24. Detection of virulent strains of Streptococcus suis type 2 and highly virulent strains of Streptococcus suis type 1 in tonsillar specimens of pigs by PCR
25. Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries
26. Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine